Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ASAspire Biopharma Holdings, Inc. logo

Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ Capital Market · Currency in USD
$8.80 ▼ -0.10 (-1.12%)
At close: Oct 23, 4:00 PM ET. Market closed.
$8.88 ▲ +0.08 (+0.91%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$8.90
Open
$8.78
Day's Range
$8.67 – $8.85
52 Week Range
$0.11 – $562.80
Volume
14,558
Avg. Volume
660,570
Market Cap
$1.02M
Beta (5Y Monthly)
0.15
PE Ratio (TTM)
--
EPS (TTM)
-$10.65
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Aspire Biopharma Holdings, Inc.

Sector
Healthcare
Industry
Medical - Pharmaceuticals
Full-time employees
2
CEO
Kraig T. Higginson

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations.

Earnings

DateEst.Actual
Aug 13, 2026–-$1.00
May 15, 2026–-$20.57
Mar 30, 2026–-$3.15
Nov 14, 2025–-$0.04
Aug 13, 2025–-$0.04
May 14, 2025–-$16.80

Get free alerts on ASBP and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.